Back

Safety and efficacy of valsartan-sacubitril in a cohort of patients with symptomatic heart failure receiving small doses of ACE

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Treatment Treatment HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Argyrios Ntalianis

Alexandra University Hospital, Athens (Greece)

67 More presentations in this session

Presentation thumbnail
Combined therapy with ACEI/ARB, beta-blocker, statin, antithrombotic drug and cardiovascular mortality in comorbide patients with heart failure, coronary artery disease, arterial hypertension
Slides
Presentation thumbnail
Heart failure over 19 years: are we on the right way?
Presentation thumbnail
B-blockers and prognosis in cardiac amyloidosis
Doctor E. Repasos (Athens, GR)
Presentation thumbnail
Barriers and motivations to physical activity in heart failure patients; is a specific approach needed for women?
Professor T. Jaarsma (Linkoping, SE)
Abstract
Presentation thumbnail
Barriers and challenges in self-care for heart failure patients with different cultural backgrounds
Professor T. Jaarsma (Linkoping, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Treating heart failure in adult congenital heart disease: A-Z
thumbnail
Congress Presentation
How can we increase adherence to medical treatment in heart failure patients? A questionnaire study
thumbnail
Congress Presentation
Audience Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources